Our Journey Beyond Sunset Boulevard
Evidence-based Analysis of Tumor-Targeted Gene- and Immuno-Therapies Shine a Critical Spotlight on 'True' Long-Term Cancer-Free Survival
Gordon, Erlinda M. (editor)
Hall, Frederick L. (editor)
The revival of DeltaRex-G (formerly Rexin-G)'”the first proactive tumor-hunting/tumor-killing biomedicine of this kind in history'”returned active tumor surveillance and a precision-guided 'silver bullet' (dnG1 killer gene) to the cancer clinic with 'Expanded Access' in 2019. Empowered by US Right-to-Try legislation, while honoring ethical principles of 'informed consent,' this unique graphic/picturesque presentation of clinical and translational medicine is intended for postmodern (post-Enlightenment) layman readers, including cancer patients, students, researchers, and future practitioners in the field of precision gene-based medicine. Confronting logical fallacies in popular opinion, the authors present newsworthy, up-to-date clinical research documenting the successful management of refractory metastatic cancers with tumor-targeted gene therapy vectors'”validating 'pathotropic' (disease-seeking) tumor targeting avant la lettre.
ISBN9781839694165, 9781839694158, 9781839694172
Publication date and place2021